Effects of oxygen therapy on systemic inflammation and myeloperoxidase modified LDL in hypoxemic COPD patients

Atherosclerosis

Volumn 205, Issue 2, 2009, Pages 360-362

  Zouaoui Boudjeltia, K ^a   Tragas, G ^a   Babar, S ^a   Moscariello, A ^a   Nuyens, V ^a   Van Antwerpen, P ^b   Gilbert, O ^a   Ducobu, J ^a   Brohee, D ^a   Vanhaeverbeek, M ^a   Van Meerhaeghe, A ^a  

^a CHU Andre Vesale   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Atherosclerosis; COPD; IL 8; Inflammation; LDL; Myeloperoxidase; Oxidation; Oxygen therapy

Indexed keywords

APOLIPOPROTEIN B; CARBOXYHEMOGLOBIN; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN; MYELOPEROXIDASE;

ARTERIAL GAS; ATHEROGENESIS; ATHEROSCLEROSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOXEMIA; INFLAMMATION; LETTER; LEUKOCYTE COUNT; LIPOPROTEIN BLOOD LEVEL; NEUTROPHIL COUNT; OXIDATIVE STRESS; OXYGEN THERAPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING CESSATION;

CHOLESTEROL, LDL; HUMANS; INFLAMMATION; INTERLEUKIN-8; OXIDATIVE STRESS; OXYGEN; OXYGEN INHALATION THERAPY; PEROXIDASE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

EID: 67650901946     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.01.028     Document Type: Letter

References (16)

1. Sin D.D., and Man S.F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107 (2003) 1514-1519
2. Mannino D.M., Buist A.S., Petty T.L., Enright P.L., and Redd S.C. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 58 (2003) 388-393
3. McGarvey L.P., John M., Anderson J.A., Zvarich M., and Wise R.A. TORCH Clinical Endpoint Committee Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 62 (2007) 411-415
4. Takabatake N., Nakamura H., Abe S., et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-α system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161 (2000) 1179-1184
5. Kim K.S., Rajagopal V., Gonsalves C., Johnson C., and Karla V.K. A novel role of hypoxia-inducible factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells. J Immunol 177 (2006) 7211-7224
6. Moguilevsky N., Zouaoui Boudjeltia K., Babar S., et al. Monoclonal antibodies against LDL progressively oxidized by myeloperoxidase react with ApoB-100 protein moiety and human atherosclerotic lesions. Biochem Biophys Res Commun 323 (2004) 1223-1228
7. Bratel T., Wennlund A., and Carlström K. Impact of hypoxaemia on neuroendocrine function and catecholamine secretion in chronic obstructive pulmonary disease (COPD). Effects of long-term oxygen treatment. Respir Med 94 (2000) 1221-1228
8. Zouaoui Boudjeltia K., Moguilevsky N., Legssyer I., et al. Oxidation of low-density lipoproteins by myeloperoxidase at the surface of endothelial cells: an additional mechanism to subendothelium oxidation. Biochem Biophys Res Commun 325 (2004) 434-438
9. Bleeke T., Zhang H., Madamanchi N., Patterson C., and Faber J.E. Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species. Circ Res 94 (2004) 37-45
10. Griendling K.K., Sorescu D., and Ushio-Fukai M. NAD (P) H oxidase: role in cardiovascular biology and disease. Circ Res 86 (2000) 494-501
11. Marquez L.A., Dunford H.B., and Van War H. Kinetic studies on the reaction of compound II of myeloperoxidase with ascorbic acid. Role of ascorbic acid in myeloperoxidase function. J Biol Chem 265 (1990) 5666-5670
12. Heinecke J.W. Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis. Am J Cardiol 91 (2003) 12A-16A
13. Buffon A., Biasucci L.M., Liuzzo G., D'Onofrio G., Crea F., and Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 347 (2002) 5-12
14. Agusti A. Thomas a Neff lecture. Chronic obstructive pulmonary disease: a systemic disease. Proc Am Thorac Soc 3 (2006) 478-481
15. Zouaoui Boudjeltia K., Legssyer I., Van Antwerpen P., et al. Triggering of inflammatory response by myeloperoxidase-oxidized LDL. Biochem Cell Biol 84 (2006) 805-812
16. Inoue T., Komoda H., Nonaka M., Kameda M., Uchida T., and Node K. Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease. Int J Cardiol 124 (2008) 319-325